The Most Expensive System, and Still Failing
The American healthcare system is often praised for its brilliance. It is home to world-class hospitals, highly trained specialists, extraordinary emergency interventions, and some of the most advanced medical technology on earth. At its best, it can do remarkable things. It can save premature infants, transplant failing organs, target cancers with astonishing precision, and keep people alive through illnesses that would have been fatal a generation ago.
But that is not the same as having a healthcare system that works.
A healthcare system should be judged not only by what it can achieve in exceptional cases, but by what it reliably delivers to ordinary people. By that measure, the American system is failing. The United States spends far more on healthcare than any other wealthy nation, yet millions of people still delay treatment, struggle to afford prescriptions, face medical debt, or find themselves trapped in a maze of billing, prior authorization, coverage restrictions, and administrative confusion. Even people with insurance often discover that being covered is not the same as being protected.
That is the contradiction at the heart of American healthcare. We have built the most expensive system in the world, but not the most humane, accessible, or trustworthy. Patients are asked to navigate financial complexity at the very moment they need clarity and care most. Doctors and nurses are increasingly forced to work inside a bureaucracy that treats care as a managed expense. Families confronting illness are made to think about coverage rules, deductibles, denials, and networks when their attention should be on healing. A system designed around patients would not do this. A system designed around revenue does.
That is why the problem runs deeper than waste, inefficiency, or political stalemate. American healthcare is not merely underperforming. It is structurally misaligned. Too many of its most powerful incentives point away from the patient and toward profit, market leverage, cost shifting, administrative control, and institutional self-protection. Insurers are rewarded for limiting expenditures. Pharmaceutical companies are rewarded for maximizing revenue. Hospital systems are rewarded for expanding profitable service lines and protecting margins. Every major player can defend its behavior as rational within the logic of the market. But taken together, those rational behaviors produce something deeply irrational for the people who need care.
This is what makes the crisis so difficult to dismiss. The suffering people experience inside the system is not accidental. It is not simply the unfortunate byproduct of complexity. It is the predictable result of a system that has been built to finance care, price care, delay care, and profit from care more effectively than it has been built to provide care effectively. That does not mean every doctor, insurer, hospital, or drug company is acting in bad faith. It means the structure itself rewards the wrong things and obstructs or delays some of the right things.
And those rewards shape everything downstream. They shape which kinds of care are easiest to access, which treatments are most profitable to develop, which services are expanded or neglected, how much time clinicians spend with patients, and how much hardship families are expected to absorb on their own. They shape whether illness is treated first as a human emergency or as a financial event to be processed.
So when we say the healthcare system is broken, we should be clear about what that means. We do not mean that no one receives excellent care. We do not mean that medicine has ceased to advance. We mean that the overall system asks too much of the sick, protects the powerful more reliably than the vulnerable, and produces fear and financial strain where there should be security and care.
This article makes that case directly. It will show what “broken” looks like in everyday life, how the system came to be this way, why other countries do better, and why meaningful reform remains so difficult. The American healthcare system is not failing despite its design. In too many ways, it is failing because of it.
What “Broken” Looks Like for Patients
A broken healthcare system is not something most people encounter first as an idea. They encounter it as a decision they should never have to make. It is the person who feels something is wrong but waits to seek care because they are afraid of the bill. It is the family that hesitates before going to the emergency room because they do not know what their insurance will actually cover. It is the patient who leaves the doctor’s office with a prescription in hand and then stands at the pharmacy counter calculating what can be postponed, reduced, or simply done without. Long before people understand the policy structure, they understand the feeling: getting sick in America is financially dangerous.
That fear is not limited to the uninsured. One of the clearest signs that the system is broken is that even people who have insurance often move through it with insecurity, confusion, and dread. Coverage may come with deductibles so high that routine care still feels unaffordable. It may depend on narrow networks, opaque formularies, and prior authorization rules that can turn even straightforward treatment into a bureaucratic contest. Patients are told they are protected, but many discover that protection is conditional, partial, and full of traps. Being insured is often presented as the solution. In practice, it can be little more than a complicated permission slip.
The result is that patients are forced to think like claims managers when they should be free to think like patients. Before scheduling a scan, filling a prescription, seeing a specialist, or agreeing to a recommended procedure, they are expected to ask a set of questions that have little to do with healing and everything to do with cost control. Is the doctor in the network? Is the hospital covered? Does this require prior authorization? Will the insurer deny it? Is there a cheaper drug the plan wants to try first? Will the bill arrive months later with charges no one explained in advance? Illness already places people in a vulnerable position. American healthcare adds financial uncertainty and administrative risk on top of it.
Even when care is available, it is often made unnecessarily hard to reach. A physician may believe a test or treatment is necessary, but the insurer may delay approval. A patient may finally secure an appointment, only to discover that the next stage of care requires a new referral, a different network, another approval, or a new round of paperwork. Someone with a serious condition can quickly find that they are not simply fighting disease. They are fighting a system of denials, delays, coding rules, contradictory notices, and phone trees that seem designed to exhaust them into compliance or surrender. The burden of making healthcare work is repeatedly shifted onto the people least able to carry it.
What makes this especially cruel is that the burden is not distributed evenly. People with money, time, education, stable employment, and strong support systems are often better positioned to combat the system’s failures. They can pay out of pocket, dispute charges, travel farther for care, take time off work, or hire help to navigate complexity. Those without those advantages are far more exposed. For them, the system’s inefficiencies are not irritating. They are destabilizing. A missed diagnosis, delayed treatment, denied medication, or unexpected bill can trigger a cascade of harm that extends far beyond health into housing, work, caregiving, and basic security.
The damage does not stop with patients. Clinicians are trapped inside the same machinery. Doctors, nurses, and support staff are increasingly required to spend time documenting for reimbursement, negotiating with insurers, responding to utilization reviews, and meeting productivity demands that treat care as a measurable output rather than a human relationship. Patients feel that this is due to rushed appointments, long waits, fragmented follow-up, and burned-out caregivers who are trying to practice medicine within a business system that keeps pulling them away from the bedside. A healthcare system that drains time, trust, and attention from the people giving care is not merely inefficient. It is actively undermining care itself.
This is what “broken” looks like in ordinary life. It looks like hesitation where there should be confidence. It looks like paperwork where there should be clarity. It looks like debt where there should be protection. It looks like a patient entering one of the most vulnerable moments of life and discovering that the system surrounding them is not organized first around relief, but around cost, control, and institutional advantage.
That is why the failures of American healthcare cannot be dismissed as unfortunate side effects of a complicated system. They are experienced too consistently, by too many people, in too many forms. For patients, “broken” does not mean that good care never exists. It means that access to care has become unpredictable, adversarial, and punishing in ways that no humane system should accept.
How We Built a Broken System
The failures of American healthcare did not arise from one bad law, one greedy industry, or one moment of political neglect. They emerged over decades, through a series of choices that made the arrangement more profitable, more administratively complex, and more protective of institutions than of patients. What exists now is not a coherent public structure organized around care. It is a layered and often contradictory arrangement built by employers, insurers, hospital systems, pharmaceutical companies, investors, regulators, and professional gatekeepers, each shaping healthcare to serve its own logic. The result is a system that can produce extraordinary medicine while making ordinary care unnecessarily difficult, expensive, and adversarial.
One of the most consequential choices was to build access to care through insurance rather than guaranteeing care more directly. In the United States, insurance became the gateway through which patients reach care, and over time, that gateway became more restrictive and more powerful. Insurers do not simply pay claims after care is delivered. They shape care in advance through network design, prior authorization, formularies, utilization review, and reimbursement rules. Each of these mechanisms can be defended as a means of controlling waste, managing risk, and containing costs across a large population. But that is exactly where the problem begins. A structure designed to manage population-level expenditure will not always serve the individual patient standing before a doctor. What is statistically efficient for the insurer can be dangerous, delaying, or simply degrading for the person who needs care now.
Once insurance became the dominant organizing force, cost control moved to the bedside. Treatment decisions were no longer governed solely by clinical judgment and patient need. They became subject to financial review, procedural hurdles, and administrative skepticism. A physician may recommend one medication, but the patient is required to try another first because it is cheaper. A scan may be delayed while authorization is sought. A specialist may be technically available but effectively inaccessible because of network restrictions or referral requirements. These obstacles are often described in bureaucratic language, but their meaning is plain enough: cost management has been embedded directly into the experience of illness. Patients feel this not as efficiency, but as delay, uncertainty, and risk.
At the same time, pharmaceutical incentives are further distorting care. Drug companies produce important treatments, and no serious critique should ignore that. But they do so inside a market that rewards recurring revenue, patent protection, pricing leverage, and strategic control over competition. The therapies that generate the most reliable profits are often those that can be prescribed continuously, extended across large populations, and protected from lower-cost alternatives for as long as possible. Insulin offers a vivid example. It is not a new miracle drug, yet for years it remained emblematic of a pricing structure in which a life-sustaining medication could become financially punishing for the people who depended on it every day. That does not mean companies refuse to pursue breakthrough treatments or cures. It does mean the financial architecture of American medicine is naturally more hospitable to long-term treatment markets than to affordability or resolution. In a system built for profit, the question is not only whether a treatment works. It is whether it can be monetized at scale.
Hospitals and health systems adapted to the same pressures. As healthcare financing became more fragmented and reimbursement more contested, providers increasingly had to behave like corporate actors in order to survive. Hospitals consolidated, expanded administrative departments, optimized coding, protected profitable service lines, and negotiated aggressively with payers. Many physician practices were absorbed into larger systems or investment-backed groups. In some markets, that consolidation has gone even further, with insurers, providers, pharmacy benefit managers, and pharmacies operating under the same corporate umbrella. The result is a form of vertically integrated power that can sharply reduce competition and leave patients trapped inside systems that control not only where care is delivered, but how it is approved, priced, and paid for. The language of healthcare grew more commercial: utilization, margins, payer mix, revenue cycle, and strategic growth. None of this happened because hospitals stopped caring about patients. It happened because the structure rewarded financial sophistication and punished institutional weakness. But once healthcare institutions have to think like corporations to survive, they inevitably begin to treat patients not only as people in need, but as units moving through a business arrangement.
There is another layer to how healthcare became broken, and it lies within medicine itself. Care is not shaped only by business incentives. It is also shaped by prestige, hierarchy, academic funding, journal power, and dominant theories that can become institutionally entrenched. In principle, medicine is supposed to correct itself in light of better evidence. In practice, powerful figures and dominant frameworks often influence which questions are funded, which findings are amplified, which alternatives are treated seriously, and which dissenting views are marginalized. When one theory becomes too central to careers, grants, and institutional identity, it can become harder for the field to challenge itself honestly. The point is not that medicine should avoid consensus. The point is that medicine is a human institution, and human institutions are often slow to revise themselves when too much status and power depend on staying the course.
All of these elements reinforced one another. Insurers normalized delay in the name of efficiency. Pharmaceutical companies normalized pricing power in the name of innovation. Hospitals normalized corporate behavior in the name of survival. Professional institutions normalized intellectual gatekeeping in the name of scientific rigor. Each part of the system could justify itself in isolation. Each could claim necessity. But together, they created a healthcare system in which the patient became increasingly secondary to the machinery of care.
That is how healthcare became broken. Not because no one intended to help the sick, but because it was gradually reorganized around financial, bureaucratic, and institutional priorities that took on lives of their own. Every major actor learned how to survive, protect itself, and expand its leverage. What no one protected with equal force was the patient’s ability to receive timely, affordable, comprehensible care.
That is the deeper story of American healthcare. It did not simply become expensive. It became structurally misaligned. Once a structure is built to reward revenue, delay, control, and self-preservation, it should not surprise us when patients experience it not as care, but as a struggle.
Why Other Countries Do Better
One of the clearest signs that American healthcare is broken is that its failures are not universal. Other wealthy countries face aging populations, rising chronic disease, workforce shortages, political conflict, and the high cost of modern medicine. They are not operating under ideal conditions. Yet many of them still manage to provide broader access, lower financial risk, and less administrative chaos than the United States. That matters because it exposes a truth Americans are often encouraged to ignore: our problems are not simply the unavoidable cost of complexity or innovation. They are the result of how we have chosen to organize care.
What makes this comparison especially powerful is that no single foreign model explains it. Countries with very different systems still manage to outperform the United States on some of the measures that matter most to patients. Britain’s National Health Service, Germany’s tightly regulated multi-payer model, Canada’s provincial single-payer approach, and Japan’s hybrid system are not interchangeable. They differ in financing, delivery, choice, and governance. But despite those differences, many of them do a better job ensuring that people can actually use healthcare without the same degree of financial fear, insurance instability, and administrative burden that Americans have come to accept as normal. That should force a basic question: if multiple models do better, why does the wealthiest country in the world do so badly?
One answer is that those systems begin from a different premise. In much of the developed world, healthcare is treated first as a public responsibility and only second as a market opportunity. That does not eliminate private actors or guarantee perfection. But it changes the moral center of the arrangement. Basic access is not tied so tightly to employment, to the fine print of insurance products, or to a patient’s ability to navigate an obstacle course of denials and billing rules. People are more likely to remain connected to care even when they lose a job, change circumstances, or become too sick to manage bureaucratic complexity. That continuity matters. A healthcare system works better when it is built to keep patients in care rather than constantly threatening to push them out.
Other countries also tend to impose far less administrative friction between patients and the care they need. In the United States, a staggering amount of time and money is consumed figuring out who is covered, under what conditions, at which rate, through which network, with which authorization, and under what billing code. Every layer of that complexity creates another opportunity for delay, denial, confusion, or cost shifting. In many higher-performing systems, reimbursement structures are still regulated and sometimes bureaucratic, but they are generally more coherent and less adversarial. Patients are less likely to find themselves acting as negotiators between disconnected institutions. Clinicians are less likely to spend so much of their working lives battling paperwork that has little to do with medicine. The point is not that those systems lack rules. It is that their rules are less consumed by the effort to defend competing financial interests.
Another difference is the role of primary care. Many better-performing systems put far more emphasis on building a strong front door into healthcare. They invest more deliberately in family medicine, continuity of care, prevention, and early intervention. That makes a difference not only in outcomes, but in the lived experience of care. When people can reliably see a primary care physician, build trust over time, and address problems before they become emergencies, the structure functions more stably and with less waste. In the United States, by contrast, primary care is often overburdened, undercompensated, and treated as less valuable than procedure-driven specialty care. That imbalance reflects the deeper logic of the arrangement: it is often more profitable to intervene dramatically than to care consistently.
Financial protection is another area where the contrast is hard to ignore. In many peer nations, people may still pay taxes, premiums, or some out-of-pocket costs, but they are far less likely to experience illness as a direct threat to their household finances. They are less likely to face large surprise bills, less likely to accumulate medical debt as a normal consequence of being sick, and less likely to postpone necessary treatment because the cost is too uncertain or too high. That alone marks a profound difference in values. A humane healthcare system does not demand that people prove their financial resilience while they are physically vulnerable.
To acknowledge that other countries do better is not to pretend they have solved everything. Many struggle with wait times, staffing shortages, funding disputes, regional disparities, and public frustration. Some patients in those systems complain about bureaucracy or seek faster care through private channels when they can afford it. Those problems are real, and they should be admitted plainly. But they do not erase the broader point. A system does not have to be perfect to be more just, more coherent, or less punishing than ours. The question is not whether another country has achieved utopia. The question is whether ordinary people are more likely to receive care without fear, debt, and institutional combat. In many cases, they are.
That is why international comparison matters so much to this argument. It strips away the comforting myth that America’s healthcare failures are somehow the unavoidable price of excellence. Other countries also have advanced hospitals, modern medicine, and trained specialists. They also innovate, rationalize in one way or another, and struggle with cost. Yet many have still managed to build systems that are simpler, more protective, and less openly hostile to the patient. They show that the American model is not inevitable. It is a choice.
And that may be the most damning point of all. The United States has chosen to preserve fragmentation, whereas others, under different political traditions and historical conditions, have built stronger expectations of coherence. It has chosen to preserve layers of profit-taking, even as others imposed stronger public guardrails. It has chosen to tolerate a level of financial exposure, administrative waste, and insurance dependence that many peer nations would consider unacceptable. Other countries do better not because they discovered some magical formula or simply made better choices in a vacuum, but because their systems were built on foundations that gave public obligation a stronger place from the start. America, by contrast, has organized healthcare around competing institutions and financial leverage, and patients live with the consequences.
Why Change Is So Hard
If the failures of American healthcare are so visible, the obvious question is why it has not been meaningfully repaired. Patients see the damage. Clinicians complain about it. Employers feel the cost. Politicians campaign against it. Nearly everyone agrees, at least in the abstract, that something is wrong. And yet the structure persists. The reason is not that those failures are hidden. It is that the people who suffer most from them are fragmented and temporary, while the institutions that benefit from them are permanent, organized, and powerful.
That imbalance is one of the deepest reasons reform stalls. Patients move through the structure episodically. They are united by vulnerability, but separated by diagnosis, geography, age, insurance status, and circumstance. One person is fighting a denial for cancer treatment. Another is drowning in a hospital bill. Another cannot find a mental health provider who accepts their insurance. Another is trapped in a months-long prior authorization fight over medication. These experiences are common enough to reveal a pattern, but they are lived one crisis at a time. The suffering is real, but it is scattered. By contrast, the institutions inside healthcare are not scattered at all. Insurers, hospital associations, pharmaceutical companies, private equity firms, large health systems, and lobbying organizations are permanent actors. They have money, staff, legal teams, trade groups, political relationships, and a daily incentive to protect the current arrangement.
That asymmetry shapes everything. The people most harmed by the arrangement are often too sick, too busy, too financially strained, or too individually isolated to organize sustained pressure for reform. The institutions that profit from it, however, do not have to improvise their defense. They are built for it. They show up every day with a unified interest in preserving revenue, leverage, and flexibility. Reform is never a simple contest between what is humane and what is not. It becomes a contest between diffuse human need and concentrated institutional power. In American politics, concentrated power usually has the advantage.
Fragmentation makes reform harder in another way: it diffuses blame so effectively that accountability becomes almost impossible to pin down. When care is too expensive, insurers blame hospitals, hospitals blame drug companies, drug companies blame pharmacy benefit managers, employers blame insurers, and politicians blame each other. Every sector can point to costs imposed by another sector. Every player can present itself as constrained by someone else’s greed, bureaucracy, or bargaining power. Patients experience the consequences directly, but the architecture ensures that responsibility remains muddy. A structure engineered to scatter blame becomes very difficult to confront honestly, because everyone can identify a villain without confronting the design.
That design is reinforced by the absence of a single switch to flip. American healthcare is not one machine. It is a densely interconnected market of contracts, regulations, payment structures, tax incentives, patent protections, employer benefit systems, federal programs, state programs, and private actors that all depend on and compete with one another. Change one part, and another part reacts. Reduce drug prices, and pharmaceutical companies warn of reduced innovation. Limit insurer controls, and payers warn of premium increases. Cut hospital reimbursement, and providers warn of closures or service reductions. Expand public coverage, and critics warn of taxes or government overreach. Some of these objections are self-serving, some are partly true, and many are both at once. That is what makes reform so difficult. Every meaningful improvement threatens an established interest, and every established interest has a voice.
There is also a cultural reason change remains elusive. Americans have never fully agreed on what healthcare is supposed to be. It is spoken of as a right, a market, a personal responsibility, a public necessity, an employment benefit, and a business sector, often all at the same time. Those conflicting ideas have been layered on top of one another for decades, producing a structure that cannot decide whether the patient is a citizen to be protected, a consumer to be sorted, or a revenue stream to be managed. Until that contradiction is confronted more directly, reform efforts will keep colliding with one another at the level of basic values. The country cannot build a coherent healthcare system while remaining incoherent about what healthcare is for.
Another reason reform lacks urgency is that it still works well enough for enough influential people to blunt the demand for transformation. Many Americans with stable income, strong employer coverage, access to major hospital systems, and enough financial cushion to absorb surprise costs experience healthcare as maddening but survivable. They may hate the paperwork, resent the bills, and complain about insurer interference, but when they need major care, they often still receive it. That matters politically. Systems rarely change because they are unfair in principle. They tend to change when people with influence begin to find the unfairness intolerable. American healthcare has managed to distribute pain broadly, but not evenly enough to force that reckoning.
And beneath all of this lies the hardest truth of all: the arrangement is not merely broken in some accidental or chaotic way. It is functioning according to the incentives built into it. Insurers are rewarded for controlling expenditures. Drug companies are rewarded for maximizing return. Hospital systems are rewarded for protecting margins and expanding profitable services. Investors are rewarded for finding leverage in every corner of care. Professional institutions are rewarded for defending prestige and influence. Each major player is behaving rationally within the logic of the environment it inhabits. The tragedy is that these rational strategies do not add up to a rational healthcare system. They add up to one in which the patient repeatedly comes last.
That is why change is so hard. The arrangement’s beneficiaries are permanent. Its victims are temporary. The people who endure the worst of it encounter it in moments of illness, fear, and dependency, then move on if they can. The institutions that benefit from it never move on. They remain in place, funded, connected, and prepared to shape every debate about what comes next. A structure like that does not resist change because no one knows it is failing. It resists change because too many powerful actors are succeeding by making the system fail for everyone else. It is a win-lose arrangement in a system that should have been built for win-win care.
What Our System Is Really Designed to Do
By now, the pattern should be impossible to miss. The American healthcare system is not broken merely because it is expensive, confusing, or politically difficult to reform. Its deepest incentives are misaligned. Again and again, the system asks what can be billed, denied, delayed, priced, negotiated, or monetized before it asks what the patient needs. That is not a secondary flaw. It is the organizing logic of the structure.
This is what makes the crisis so morally serious. People do not enter the healthcare system at moments of strength. They enter it when they are sick, afraid, in pain, uncertain, or responsible for someone they love. Those are the moments when a decent society should make care simpler, clearer, and easier to trust. Instead, American healthcare so often does the opposite. It confronts vulnerability with paperwork, urgency with delay, illness with financial exposure, and dependence with institutional indifference. Even when excellent care is eventually delivered, it is too often delivered through a gauntlet of obstacles that should never have been there in the first place.
The usual defense is that the structure is merely complicated, as though complexity were a force of nature and not the result of human choices. But complexity in American healthcare is not neutral. It serves functions. It protects revenue streams. It obscures accountability. It gives institutions room to shift costs, manage risk, and preserve leverage. It allows every major player to claim necessity while the patient absorbs the consequences. In that sense, healthcare is not malfunctioning at random. It is doing exactly what systems do when built around competing financial interests rather than care.
That is why incremental language often fails to capture the problem. Efficiency improvements, transparency rules, and better consumer protections may help. They do not reach the deeper issue. The system has been built to reward the wrong achievements. It rewards financial extraction more reliably than prevention. It rewards administrative control more reliably than trust. It rewards market power more reliably than continuity of care. It rewards institutions for surviving one another, while leaving patients to survive the system itself.
And yet the conclusion is not hopeless. If this crisis has been built through choices, it can also be changed through choices. Other countries have already shown that healthcare can be organized with more coherence, more public accountability, and less financial harm. Even within the United States, there are clinicians, caregivers, advocates, and reformers who know exactly what more humane care looks like because they practice it every day, despite the system around them. The problem is not that we lack intelligence, resources, or medical skill. The problem is that we have tolerated a set of incentives that place those strengths in service to the wrong ends.
So the most honest way to say it is also the clearest. Our healthcare system is broken because it was built for profit, not for patients. It protects institutions more reliably than people, manages costs more aggressively than suffering, and defends its own machinery more fiercely than the human beings who depend on it. Until that changes, the fear, debt, delay, and indignity people experience will not be unfortunate side effects. They will be predictable outcomes.
And that is the point we can no longer afford to soften. A healthcare system should exist to care for the sick. If it consistently asks the sick to bear the burden of its business model, then it is not merely struggling. It is failing at its most basic purpose.
